Skip to main content
Erschienen in: World Journal of Urology 12/2023

18.11.2023 | Invited Review

Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis

verfasst von: Andrey Morozov, Mark Taratkin, Anastasia Shpikina, Yaron Ehrlich, Jonathan McFarland, Alim Dymov, Vasiliy Kozlov, Harun Fajkovic, Juan Gomez Rivas, Lukas Lusuardi, Jeremy Yuen-Chun Teoh, Thomas Herrmann, Jack Baniel, Dmitry Enikeev

Erschienen in: World Journal of Urology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare long-term reoperation rate and functional outcomes between EEP (endoscopic enucleation of the prostate) and TURP (transurethral resection of the prostate).

Evidence acquisition

A systematic literature review of Medline, Scopus, and Web of Science was conducted with primary outcome assessed being reoperation rate and secondary outcomes after a long term (> 3 years) being functional outcomes or related values (prostate volume, PSA level, etc.).

Evidence synthesis

Five studies were found with long-term follow-up 4–7 years. EEP reoperation rate ranged from 0 to 1.27%, while from 1.7 to 17.6% for TURP. Meta-analysis showed significantly lower OR for EEP, 0.27 (95% CI 0.24–0.31), with notable homogeneity of the results, I2 = 0%. Long-term Qmax and IPSS were significantly better for EEP. Qmax pooled mean difference was 1.79 (95% CI 1.72–1.86) ml/s with a high concordance among the studies, I2 = 0%. IPSS mean difference −1.24 (95% CI − 1.28 to − 1.2) points, I2 = 57% but QoL did not differ, with mean difference being 0.01 (95% CI − 0.02 to 0.04), I2 = 0%. IIEF-5 score was also significantly better for EEP, mean difference 1.08 (95% CI 1.03–1.13), but heterogeneity was high, I2 = 70%. PSA level and prostate volume were only reported in one study and favored EEP slightly yet statistically significant.

Conclusion

EEP had a significantly lower reoperation rate and better functional outcomes (Qmax and IPSS) at long term compared with TURP. It may also be beneficial in terms of IIEF-5, PVR, and PSA level.
Literatur
1.
Zurück zum Zitat Naspro R, Gomez Sancha F, Manica M, Meneghini A, Ahyai S, Aho T et al (2017) From “gold standard” resection to reproducible “future standard” endoscopic enucleation of the prostate: what we know about anatomical enucleation. Minerva Urol Nefrol 69(5):446–458PubMed Naspro R, Gomez Sancha F, Manica M, Meneghini A, Ahyai S, Aho T et al (2017) From “gold standard” resection to reproducible “future standard” endoscopic enucleation of the prostate: what we know about anatomical enucleation. Minerva Urol Nefrol 69(5):446–458PubMed
2.
Zurück zum Zitat Aho T, Armitage J, Kastner C (2020) Anatomical endoscopic enucleation of the prostate: the next gold standard? Yes! Andrologia 52(8):e13643CrossRefPubMed Aho T, Armitage J, Kastner C (2020) Anatomical endoscopic enucleation of the prostate: the next gold standard? Yes! Andrologia 52(8):e13643CrossRefPubMed
3.
Zurück zum Zitat Elkoushy MA, Elhilali MM (2016) Management of benign prostatic hyperplasia larger than 100 ml: simple open enucleation versus transurethral laser prostatectomy. Curr Urol Rep 17(6):44CrossRefPubMed Elkoushy MA, Elhilali MM (2016) Management of benign prostatic hyperplasia larger than 100 ml: simple open enucleation versus transurethral laser prostatectomy. Curr Urol Rep 17(6):44CrossRefPubMed
5.
Zurück zum Zitat Das AK, Han TM, Hardacker TJ (2020) Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia. Can J Urol 27(S3):44–50PubMed Das AK, Han TM, Hardacker TJ (2020) Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia. Can J Urol 27(S3):44–50PubMed
6.
Zurück zum Zitat Magistro G, Schott M, Keller P, Tamalunas A, Atzler M, Stief CG et al (2021) Enucleation vs resection: a matched-pair analysis of TURP, HoLEP and bipolar TUEP in medium-sized prostates. Urology 154:221–226CrossRefPubMed Magistro G, Schott M, Keller P, Tamalunas A, Atzler M, Stief CG et al (2021) Enucleation vs resection: a matched-pair analysis of TURP, HoLEP and bipolar TUEP in medium-sized prostates. Urology 154:221–226CrossRefPubMed
7.
Zurück zum Zitat Cornu JN, Ahyai S, Bachmann A, De La Rosette J, Gilling P, Gratzke C et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed Cornu JN, Ahyai S, Bachmann A, De La Rosette J, Gilling P, Gratzke C et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed
8.
Zurück zum Zitat Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z et al (2019) Efficacy and safety of enucleation vs resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis 22(4):493–508CrossRefPubMed Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z et al (2019) Efficacy and safety of enucleation vs resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis 22(4):493–508CrossRefPubMed
9.
Zurück zum Zitat Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94(10):1201–1208CrossRefPubMed Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94(10):1201–1208CrossRefPubMed
10.
Zurück zum Zitat Yin L, Teng J, Huang C-J, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611CrossRefPubMed Yin L, Teng J, Huang C-J, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611CrossRefPubMed
11.
Zurück zum Zitat Enikeev D, Misrai V, Rijo E, Sukhanov R, Chinenov D, Gazimiev M et al (2021) EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: a critical appraisal of the guidelines using the AGREE-II tool. Urol Int 106:1–10CrossRefPubMed Enikeev D, Misrai V, Rijo E, Sukhanov R, Chinenov D, Gazimiev M et al (2021) EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: a critical appraisal of the guidelines using the AGREE-II tool. Urol Int 106:1–10CrossRefPubMed
12.
Zurück zum Zitat Kuntz RM (2011) Transurethral enucleation is superior to resection. Nat Rev Urol 8(1):14–15CrossRefPubMed Kuntz RM (2011) Transurethral enucleation is superior to resection. Nat Rev Urol 8(1):14–15CrossRefPubMed
13.
Zurück zum Zitat Enikeev D, Taratkin M, Morozov A, Singla N, Gabdulina S, Tarasov A et al (2020) Long-term outcomes of holmium laser enucleation of the prostate: a 5-year single-center experience. J Endourol 34(10):1055–1063CrossRefPubMed Enikeev D, Taratkin M, Morozov A, Singla N, Gabdulina S, Tarasov A et al (2020) Long-term outcomes of holmium laser enucleation of the prostate: a 5-year single-center experience. J Endourol 34(10):1055–1063CrossRefPubMed
14.
Zurück zum Zitat Cho MC, Song WH, Park J, Cho SY, Jeong H, Oh S-J et al (2018) Long-term outcomes of laser prostatectomy for storage symptoms: comparison of serial 5-year followup data between high performance system photoselective vaporization and holmium laser enucleation of the prostate. J Urol 199(6):1591–1599CrossRefPubMed Cho MC, Song WH, Park J, Cho SY, Jeong H, Oh S-J et al (2018) Long-term outcomes of laser prostatectomy for storage symptoms: comparison of serial 5-year followup data between high performance system photoselective vaporization and holmium laser enucleation of the prostate. J Urol 199(6):1591–1599CrossRefPubMed
15.
Zurück zum Zitat Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M (2009) Levels of evidence: Oxford centre for evidence-based medicine. Centre for Evidence Based Medicine, Oxford Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M (2009) Levels of evidence: Oxford centre for evidence-based medicine. Centre for Evidence Based Medicine, Oxford
17.
Zurück zum Zitat Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408–411CrossRefPubMed Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408–411CrossRefPubMed
18.
Zurück zum Zitat Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W et al (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 189(4):1427–1431CrossRefPubMed Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W et al (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 189(4):1427–1431CrossRefPubMed
19.
Zurück zum Zitat Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed
20.
Zurück zum Zitat Gu M, Chen YB, Liu C, Wan X, Cai ZK, Chen Q et al (2018) Comparison of holmium laser enucleation and plasmakinetic resection of prostate: a randomized trial with 72-month follow-up. J Endourol 32(2):139–143CrossRefPubMed Gu M, Chen YB, Liu C, Wan X, Cai ZK, Chen Q et al (2018) Comparison of holmium laser enucleation and plasmakinetic resection of prostate: a randomized trial with 72-month follow-up. J Endourol 32(2):139–143CrossRefPubMed
21.
Zurück zum Zitat Kim A, Hak AJ, Choi WS, Paick SH, Kim HG, Park HK (2021) Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: nations-wide health insurance study. Urology 154:1–8CrossRef Kim A, Hak AJ, Choi WS, Paick SH, Kim HG, Park HK (2021) Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: nations-wide health insurance study. Urology 154:1–8CrossRef
22.
Zurück zum Zitat Huang S-W, Tsai C-Y, Tseng C-S, Shih M-C, Yeh Y-C, Chien K-L et al (2019) Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ 367:l5919CrossRefPubMedPubMedCentral Huang S-W, Tsai C-Y, Tseng C-S, Shih M-C, Yeh Y-C, Chien K-L et al (2019) Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ 367:l5919CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Moyad MA (2002) The placebo effect and randomized trials: analysis of conventional medicine. Urol Clin N Am 29(1):125–133CrossRef Moyad MA (2002) The placebo effect and randomized trials: analysis of conventional medicine. Urol Clin N Am 29(1):125–133CrossRef
24.
Zurück zum Zitat van Leeuwen JHS, Castro R, Busse M, Bemelmans BLH (2006) The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol 50(3):440–453CrossRefPubMed van Leeuwen JHS, Castro R, Busse M, Bemelmans BLH (2006) The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol 50(3):440–453CrossRefPubMed
25.
Zurück zum Zitat Stridh A, Pontén M, Arver S, Kirsch I, Abé C, Jensen KB (2020) Placebo responses among men with erectile dysfunction enrolled in phosphodiesterase 5 inhibitor trials. JAMA Netw Open 3(3):e201423CrossRefPubMedPubMedCentral Stridh A, Pontén M, Arver S, Kirsch I, Abé C, Jensen KB (2020) Placebo responses among men with erectile dysfunction enrolled in phosphodiesterase 5 inhibitor trials. JAMA Netw Open 3(3):e201423CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Speakman MJ, Cornu J-N, Gacci M, Gratzke C, Mamoulakis C, Herrmann TRW et al (2019) What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus 5(3):351–356CrossRefPubMed Speakman MJ, Cornu J-N, Gacci M, Gratzke C, Mamoulakis C, Herrmann TRW et al (2019) What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus 5(3):351–356CrossRefPubMed
27.
Zurück zum Zitat Bhat A, Blachman-Braun R, Herrmann TRW, Shah HN (2022) Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction. World J Urol 40(4):889–905CrossRefPubMed Bhat A, Blachman-Braun R, Herrmann TRW, Shah HN (2022) Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction. World J Urol 40(4):889–905CrossRefPubMed
28.
Zurück zum Zitat Oh S-J, Shitara T (2020) Enucleation of the prostate: an anatomical perspective. Andrologia 52(8):e13744CrossRefPubMed Oh S-J, Shitara T (2020) Enucleation of the prostate: an anatomical perspective. Andrologia 52(8):e13744CrossRefPubMed
29.
Zurück zum Zitat Feng L, Zhang D, Tian Y, Song J (2016) Thulium laser enucleation versus plasmakinetic enucleation of the prostate: a randomized trial of a single center. J Endourol 30(6):665–670CrossRefPubMed Feng L, Zhang D, Tian Y, Song J (2016) Thulium laser enucleation versus plasmakinetic enucleation of the prostate: a randomized trial of a single center. J Endourol 30(6):665–670CrossRefPubMed
30.
Zurück zum Zitat Enikeev DV, Glybochko PV, Alyaev YG, Rapoport LM, Sorokin NI, Enikeev ME et al (2017) Laser enucleation of the prostate (HOLEP and THULEP): a comparative effectiveness analysis in treating recurrent prostatic hyperplasia. Urologiia 4:50–54CrossRef Enikeev DV, Glybochko PV, Alyaev YG, Rapoport LM, Sorokin NI, Enikeev ME et al (2017) Laser enucleation of the prostate (HOLEP and THULEP): a comparative effectiveness analysis in treating recurrent prostatic hyperplasia. Urologiia 4:50–54CrossRef
31.
Zurück zum Zitat Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M et al (2020) Retrospective assessment of endoscopic enucleation of prostate complications: a single-center experience of more than 1400 patients. J Endourol 34(2):192–197CrossRefPubMed Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M et al (2020) Retrospective assessment of endoscopic enucleation of prostate complications: a single-center experience of more than 1400 patients. J Endourol 34(2):192–197CrossRefPubMed
32.
Zurück zum Zitat Xiao KW, Zhou L, He Q, Gao XS, Chen G, Ma YC et al (2019) Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis. Lasers Med Sci 34:815–826CrossRefPubMed Xiao KW, Zhou L, He Q, Gao XS, Chen G, Ma YC et al (2019) Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis. Lasers Med Sci 34:815–826CrossRefPubMed
33.
Zurück zum Zitat Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A et al (2021) Systematic review of the endoscopic enucleation of the prostate learning curve. World J Urol 39(7):2427–2438CrossRefPubMed Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A et al (2021) Systematic review of the endoscopic enucleation of the prostate learning curve. World J Urol 39(7):2427–2438CrossRefPubMed
34.
Zurück zum Zitat Qian X, Liu H, Xu D, Xu L, Huang F, He W et al (2017) Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis. Aging Male 20(3):184–191PubMed Qian X, Liu H, Xu D, Xu L, Huang F, He W et al (2017) Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis. Aging Male 20(3):184–191PubMed
35.
Zurück zum Zitat Liu C, Zheng S, Li H, Xu K (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184(6):2440–2445CrossRefPubMed Liu C, Zheng S, Li H, Xu K (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184(6):2440–2445CrossRefPubMed
36.
Zurück zum Zitat Gilfrich C, May M, Fahlenbrach C, Günster C, Jeschke E, Popken G et al (2021) Surgical reintervention rates after invasive treatment for lower urinary tract symptoms due to benign prostatic syndrome: a comparative study of more than 43,000 patients with long-term followup. J Urol 205(3):855–863CrossRefPubMed Gilfrich C, May M, Fahlenbrach C, Günster C, Jeschke E, Popken G et al (2021) Surgical reintervention rates after invasive treatment for lower urinary tract symptoms due to benign prostatic syndrome: a comparative study of more than 43,000 patients with long-term followup. J Urol 205(3):855–863CrossRefPubMed
Metadaten
Titel
Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis
verfasst von
Andrey Morozov
Mark Taratkin
Anastasia Shpikina
Yaron Ehrlich
Jonathan McFarland
Alim Dymov
Vasiliy Kozlov
Harun Fajkovic
Juan Gomez Rivas
Lukas Lusuardi
Jeremy Yuen-Chun Teoh
Thomas Herrmann
Jack Baniel
Dmitry Enikeev
Publikationsdatum
18.11.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-023-04666-8

Weitere Artikel der Ausgabe 12/2023

World Journal of Urology 12/2023 Zur Ausgabe

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.